![Hormone patches or creams for menopause symptoms may have lower blood pressure risk than pills | CTV News Hormone patches or creams for menopause symptoms may have lower blood pressure risk than pills | CTV News](https://beta.ctvnews.ca/national/health/2023/6/5/1_6427737/_jcr_content/root/responsivegrid/image.coreimg.jpg)
Hormone patches or creams for menopause symptoms may have lower blood pressure risk than pills | CTV News
![FDA again reprimands Ascend Therapeutics for EstroGel promos that may mislead clinicians - MM+M - Medical Marketing and Media FDA again reprimands Ascend Therapeutics for EstroGel promos that may mislead clinicians - MM+M - Medical Marketing and Media](https://www.mmm-online.com/wp-content/uploads/sites/2/2018/08/estrogel.jpg)
FDA again reprimands Ascend Therapeutics for EstroGel promos that may mislead clinicians - MM+M - Medical Marketing and Media
![Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy - Brendan J. Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox, Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy - Brendan J. Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox,](https://journals.sagepub.com/cms/10.1177/2042018820924543/asset/images/large/10.1177_2042018820924543-fig1.jpeg)
Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy - Brendan J. Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox,
![Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. | Semantic Scholar Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eab52108c0a0d40c3ac7ded5175bd96004c3edbd/4-Table3-1.png)
Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. | Semantic Scholar
![Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives - Clinical Advisor Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives - Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/oralcontraceptionts52036549_989022.jpg)